@inproceedings{inproceedings, title  = {{Efficacy and safety of dupilumab in children aged >= 6 months to < 6 years with moderate-to-severe atopic dermatitis}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Paller AS and Cork MJ and Siegfried EC and Simpson EL and Wollenberg A and Gonzalez ME and Sun Y and O'Malley JT and Bansal A}},

 volume = {{187}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 pages = {{12-12}},

 note = {{Accessed on 2024/12/22}}}